High levels of histone 3 acetylation in a promoter are usually correlated with active gene transcription[44],[45]. trophectoderm (TE) in chimeric embryos. When further cultured in ES medium without LIF or in trophoblast stem (TS) cell medium,Mbd3knockdown cells differentiate into Cidofovir (Vistide) TE cells, which express Cdx2 and, at later stages, trophoblast lineage specific marker Cadherin 3. These results suggest thatMbd3helps restrict ES cells from differentiating towards the trophectoderm lineage and is an important epigenetic player in maintaining full pluripotency of mouse Goat Polyclonal to Rabbit IgG ES cells. == Introduction == Embryonic stem (ES) cells are derived from the inner cell mass (ICM) of growing blastocysts. They maintain an undifferentiated state in defined culture conditions, but can also Cidofovir (Vistide) be induced to differentiate into diverse cell types representative of all three germ layers both in vitro and in vivo[1]. ES cells are powerful tools for expanding our knowledge in mammalian early development and are thought to hold great promise for regenerative medicine[2]. ES cells share many characteristics of ICM cells at the level of transcriptional regulation. For example, they both express pluripotent cell specific transcription factors, such asOct4andNanog[3][5]. In mouse, loss ofOct4expression by targeted gene deletion causes ES cells to develop into trophectoderm[6],[7], while deletion ofNanogcauses ES cells to differentiate into primitive endoderm[5]and to compromise PGC maturation[8]. Considerable efforts have been devoted to elucidate transcriptional networks of these and other transcription factors and their associated cofactors[9],[10]. These transcription factors have been implicated in cooperatively activating or repressing a broad range of downstream target genes[11]. However, less attention has been paid to epigenetic regulation of these lineage specific transcription factors. Recent studies have shown that the ES cell pluripotent state is critically maintained by Polycomb group (PcG) complexes that mediate suppression of key differentiation genes[12][14]. Other epigenetic studies point to Cidofovir (Vistide) similar lineage restriction schemes to govern ES cell pluripotency (reviewed in[15]). Despite these studies, detailed mechanisms of how global epigenetic control is achieved, especially how lineage specific transcription programs are suppressed in ES cells, remain to be fully elucidated (reviewed in[15],[16]). Major epigenetic modifications include DNA methylation, histone acetylation and methylation which are often closely coupled[17]. DNA methylation at the dinucleotide CpG in regulatory regions is a hallmark of stable transcriptional silencing[18]. Recruitment of specific binding proteins to methylated CpG islands is believed to repress target gene transcription[19]. On the other hand, acetylation of histone tails is critical for nucleosome structure alterations that facilitate DNA accessibility to regulatory factors[20][22]. Purification of nucleosome remodeling and histone deacetylation complex (NuRD, also known as Mi-2, NURD, or NRD) links together two epigenetic modifications: DNA methylation and histone deacetylation[23][27]. Several components of the NuRD complex have been shown to be necessary for early embryonic development. Methylated DNA-linked chromosomal remodeling and gene silencing are thought to be mediated by methyl-CpG binding (MBD) proteins[19],[28]. Unlike other mammalian MBD protein, Mbd3 does not bind to methyl-CpG biochemically. Instead, Mbd3 is directly associated with Chd4 protein as core subunits of the NuRD complex. Study ofMbd3null mice indicates that it is essential for early embryogenesis whileMbd2is dispensable for viability[29]. Since dynamic epigenetic regulations occur during ICM formation and differentiation of primary germ layers, early embryonic lethality caused byMbd3deletion may be attributed to abnormal epigenetic modifications, and therefore dysregulation of gene expression in early embryos[30],[31].Mbd3function was reported to be dispensable for ES cell growth in culture, but essential for their commitment to a full spectrum of embryonic lineages when aggregated with wild type embryos, indicating pluripotency of these cells is indeed affected[15],[32]. A detailed mechanism for restricted differentiation of theMbd3-deficient cells remains to be elucidated. Interestingly, when cultured in vitro to promote embryonic stem cell outgrowth,Mbd3-deficient ICMs Cidofovir (Vistide) fail to generate pluripotent cells[33]. This difference may be attributed to different sets of molecular factors that are required for the derivation and maintenance of the pluripotent state[15],[33]. Specification of trophectoderm is the first sign of differentiation of early mouse embryos. Studies of molecules required for the specification of the trophectoderm have led to identification of Oct4 as a negative regulator while Cdx2 as a positive transcription factor in the process. Conditional deletion ofOct4in mouse ES cells leads to trophoblast differentiation and increased expression of trophoblast-specific markers[6]. Trophoblast stem (TS) cells can be derived when these cells are cultured under conditions that promote trophoblast proliferation[34]..